The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection.

CONCLUSION: Fluoropyrimidine-based adjuvant chemotherapy may prolong the survival of patients with stages II and III BTC after R0 resection. PMID: 28086990 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28086990?dopt=Abstract

Source: Chinese Journal of Cancer - January 15, 2017 Category: Cancer & Oncology Tags: Chin J Cancer Source Type: research

More News: Cancer | Cancer & Oncology | Chemotherapy | Study